Literature DB >> 9266283

Lactate blood levels in the perioperative period of orthotopic liver transplantation.

A De Gasperi1, E Mazza, A Corti, F Zoppi, M Prosperi, G Fantini, A Scaiola, G Colella, O Amici, P Notaro, A Rocchini, F Ceresa, E Roselli, M C Grugni.   

Abstract

To investigate whether early postoperative changes in blood lactate concentration indicate the functional recovery of the newly grafted liver, changes in oxygen supply, oxygen consumption, acid-base equilibrium, and blood lactate concentrations were prospectively studied in a group of 53 postnecrotic cirrhotic patients during the various phases of orthotopic liver transplantation (preanhepatic, anhepatic, neohepatic) and for the first 48 h following reperfusion. The patients were divided into two groups according to the quality of the early graft function, as indicated by alanine aminotransferase, bile flow, and prothrombin activity: group A (49 patients), good immediate graft function and group B (4 patients), immediate graft non-function. Lactate levels rose in the same manner during the preanhepatic and anhepatic stages and peaked after revascularization of the graft. Following reperfusion, however, distinctly different blood lactate profiles were recorded in the two groups of patients. A fall in lactate concentration was recorded in group A patients, whereas a continuous rise occurred in group B patients: the difference becoming significant by the end of surgery (P < or = 0.05). During the first 48 h following revascularization of the graft, opposite trends in lactate concentration, bile flow, alanine aminotransferase, and prothrombin activity were evident in the two groups of patients: 24 h after reperfusion, lactate levels were below 2 mmol/l in 47 of 49 patients from group A, while they plateaued above 4 mmol/l in all patients from group B. Group A patients had lower alanine aminotransferase levels (P < or = 0.001), higher prothrombin activity, (P < or = 0.01), and greater bile flow (P < or = 0.02). If validated in larger series, the blood lactate profile, probably more than the absolute level, appears to be a useful indicator of the early recovery of liver metabolic capacities in the immediate postoperative period of orthotopic liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266283     DOI: 10.1007/bf02912446

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  6 in total

1.  Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.

Authors:  Cataldo Doria; Lucio Mandalá; Victor L Scott; Salvatore Gruttadauria; Ignazio R Marino
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 2.  Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?

Authors:  Andrea De Gasperi; Ernestina Mazza; Manlio Prosperi
Journal:  World J Hepatol       Date:  2016-03-08

3.  A protein biosensor for lactate.

Authors:  S D'Auria; Z Gryczynski; I Gryczynski; M Rossi; J R Lakowicz
Journal:  Anal Biochem       Date:  2000-07-15       Impact factor: 3.365

4.  The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation.

Authors:  Jeong Eun Kim; Joon Pyo Jeon; Hee Chern No; Jong Ho Choi; Sang Hoon Lee; Keon Hee Ryu; Eun Sung Kim
Journal:  Korean J Anesthesiol       Date:  2011-06-17

Review 5.  Ischemic preconditioning modulates ROS to confer protection in liver ischemia and reperfusion.

Authors:  Phillip Bystrom; Nicole Foley; Luis Toledo-Pereyra; Kelly Quesnelle
Journal:  EXCLI J       Date:  2017-04-07       Impact factor: 4.068

6.  Association Between Serum Lactate and Unsatisfactory Outcomes in Critically Ill Children in the Immediate Post-operative Period of Liver Transplantation.

Authors:  Jaime Fernández-Sarmiento; María Angélica Wilches-Cuadros; Ricardo Hernandez-Sarmiento; Hernando Mulett; Karen Moreno-Medina; Nicolás Molano; Julián Augusto Palomar Dominguez; Lorena Acevedo; Claudia Salinas; Jairo Rivera
Journal:  Front Pediatr       Date:  2022-01-24       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.